Listen Now

Topics Covered

  • Overview of Blood Cancers
  • New Research Presented at ASH
  • Disease-Specific Treatment Updates
    • Leukemia
    • Myeloproliferative Neoplasms (MPN)
    • Lymphoma
    • Multiple Myeloma
  • The Role of Clinical Trials
  • Talking with Your Health Care Team About Your Treatment Options
  • Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Attending Physician, Leukemia Service, Member, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Ruben A. Mesa, MD, FACP

Consultant Hematologist, Mayo Clinic in Arizona, Chair, Division of Hematology & Medical Oncology, Deputy Director, Mayo Clinic Cancer Center, Professor of Medicine

John P. Leonard, MD

Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Associate Dean for Clinical Research, Weill Cornell Medical College, Vice Chairman for Clinical Research, Weill Department of Medicine, Associate Director of Clinical Trials, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, Attending Physician, Chief Lymphoma Service, NewYork-Presbyterian, Director of the Joint Clinical Trials Office, Weill Cornell Medicine and NewYork-Presbyterian

Noopur Raje, MD

Associate Professor, Department of Medicine, Harvard Medical School, Director, Center for Multiple Myeloma, Division of Hematology and Oncology, Massachusetts General Hospital

Caroline Edlund, MSW

Online Support Group Program Director, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(84.2 KB)

Workshop Date

This workshop was originally recorded on January 26, 2017.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top